Clinical implication of antiphospholipid antibodies in systemic lupus erythematosus.
Stratta
P
P
Department of Nephrology, University of Turin, Italy.
Canavese
C
C
Thea
A
A
Tognarelli
G
G
Dogliani
M
M
Porcu
M C
MC
Garis
G
G
Borchiellini
A
A
Schinco
P C
PC
Vercellone
A
A
D017152:Antibodies, Antiphospholipid / Q000097:blood*; D002493:Central Nervous System Diseases / Q000150:complications / Q000276:immunology; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000097:blood; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000150:complications / Q000276:immunology*; D008181:Lupus Nephritis / Q000150:complications / Q000276:immunology; D010314:Partial Thromboplastin Time; D013921:Thrombocytopenia / Q000150:complications / Q000276:immunology; D013927:Thrombosis / Q000150:complications / Q000276:immunology
D017152:Antibodies, Antiphospholipid; D016682:Lupus Coagulation Inhibitor